Journal profile · NANOSCIENCE & NANOTECHNOLOGY-PHARMACOLOGY & PHARMACY
International Journal of Nanomedicine
ISSN 1178-2013 · Dove Medical Press Ltd. · NEW ZEALAND · Quarterly · Founded 2006
International Journal of Nanomedicine: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.7; JCR Q1 (journal website); fully open access; APC about USD 3,940; median 81 days to acceptance (150 articles, last 24 months); community-reported acceptance: 80%; 779 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Journal of Nanomedicine is published by Dove Medical Press Ltd. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics and RNA Interference and Gene Delivery, together about 37% of its articles. Its main subfields are Biomedical Engineering and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Prof. Dr. R.D.K. Misra The International Journal of Nanomedicine is a peer-reviewed, open-access journal dedicated to publishing cutting-edge research on the application of nanotechnology in the biomedical field/healthcare, where the societal need is immense. Given the rapidly advancing area of science, the journal aims to disseminate high-quality, original research that explores the potential clinical impact of nanoscale systems in the diagnosis, prevention, and treatment of diseases. The International Journal of Nanomedicine no longer accepts meta-analyses for publication. In addition, the journal will not accept study protocols or case reports, as we aim to focus on original findings that contribute to the field's development in both basic and applied nanomedicine. Some examples of topics that will be of considerable interest to the journal within the nanomedicine field are:• Nanodrug Delivery and Biosensors: Innovative approaches to targeted drug delivery systems and controlled release of therapeutics utilizing nanomaterials.• Regenerative Nanomedicine: Nanotechnology’s role in enhancing tissue repair and regeneration, including applications in stem cell therapies and wound healing.• Nanodiagnostics: Development of nanoscale diagnostic tools and techniques for early disease detection and monitoring.• Nanoinformatics: The integration of data science with nanotechnology, including computational models and informatics approaches for predicting nanomaterial behavior and interactions.• Nanotoxicity: Investigations into the safety and potential risks of nanoparticles in biological systems, evaluating their biocompatibility and long-term effects.• Nanoenegineered biomedical devices: Nanostructured or nanotextured implants with bioactive surfaces. Topics of preferred interest to the journal are processing, property and performance evaluation, and clinical application of nanoscale structures and devices that include particles, probes, vesicles, films, and sensors in the treatment of human health and point-of-care diagnostics in medical applications. In line with the dynamic nature of the field, the journal prioritizes submissions that have a clear path toward clinical application, focusing on how nanomedicine can be translated into practical therapeutic strategies. We welcome the submission of original research, clinical applications, expert opinions, reviews, and evaluations. The International Journal of Nanomedicine acknowledges the importanc
From the journal's Aims & Scope
Research area (LetPub): NANOSCIENCE & NANOTECHNOLOGY-PHARMACOLOGY & PHARMACY
Editor-in-chief R.D.K. MisraPublisher website
Editorial board by country: 28 in mainland China (about 15%); most named United States 66, Mainland China 28, United Kingdom 14, India 12, Italy 8 (182 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoparticle-Based Drug DeliveryMaterials Science17.8%
- Nanoplatforms for cancer theranosticsEngineering12.1%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology7.1%
- Graphene and Nanomaterials ApplicationsEngineering6.8%
- Nanoparticles: synthesis and applicationsMaterials Science6.4%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.3%
- Bone Tissue Engineering MaterialsEngineering5%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Nanoscience & Nanotechnology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Nanoscience & Nanotechnology | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Nanoscience & Nanotechnology | Zone 3 |
Top journal: yesReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.7LetPub ·
- Impact factor (publisher) 2025
- 8.8Publisher website ·
- 5-year impact factor (publisher)
- 10.6Publisher website ·
- CiteScore 2026-06
- 10.6LetPub ·
- CiteScore (publisher) 2025
- 1.12Publisher website ·
- SJR 2026-06
- 1.41LetPub ·
- SNIP 2026-06
- 1.12LetPub ·
- h-index
- 100LetPub ·
- h-index
- 219OpenAlex ·
- i10-index
- 7,253OpenAlex ·
- 2-year mean citedness
- 10.05OpenAlex ·
- Self-citation rate
- 4.6%LetPub ·
- Share of gold OA articles
- 98.69%LetPub ·
Volume
- Articles per year
- 751LetPub ·
- Articles per year (publisher)
- 170Publisher website ·
- Downloads per year (publisher)
- 860,079Publisher website ·
Articles by year OpenAlex count · 9,471 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 678 | 678 | 617 |
| 2025 | 779 | 779 | 7,452 |
| 2024 | 739 | 739 | 14,002 |
| 2023 | 475 | 475 | 11,628 |
| 2022 | 440 | 440 | 12,074 |
| 2021 | 538 | 538 | 22,548 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
81 daysMedian, submission to acceptance · P25–P75 67 days – 100 days
- Acceptance to online
- median 17 days (150 articles)
- Submission to online
- median 101 days
- Sample
- 150 articles with submission and acceptance dates (1,670 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1.3 monthsLetPub ·
- Average acceptance (community reports)
- 80%LetPub ·
- Acceptance rate (publisher)
- 18%Publisher website ·
- Desk decision
- 45 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,836 | — | — | |
| LetPub | USD 3,300 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websiteAI use
- AI use Formulation-Driven Innovation in Antifungal Therapy: From Nanotechnology to AI-Assisted Design
DC R, Mamani M, Baral KC, Kim GL, Jo SY, Han HK International Journal of Nanomedicine 2026, 21:636678 Published Date: 14 September 2026
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press Ltd.
- Country or region
- NEW ZEALAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 2006
- ISSN
- 1178-2013
- Print ISSN
- 1176-9114
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about International Journal of Nanomedicine
What CAS zone is International Journal of Nanomedicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Nanomedicine is in Zone 2 of Medicine, and in Zone 2 of the minor category Pharmacology & Pharmacy / Nanoscience & Nanotechnology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Nanomedicine?
The latest impact factor listed by LetPub is 8.7; CiteScore 10.6, h-index 219.
How long does peer review take at International Journal of Nanomedicine?
Based on the dates recorded on 150 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 81 days (interquartile range 67–100 days); authors report an average review time of about 1.3 months; the community-reported acceptance is “80%”; the journal's website gives an acceptance rate of 18%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is International Journal of Nanomedicine in?
The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Where are the editorial board members of International Journal of Nanomedicine based?
Of the 182 board members whose country the journal's board page names, 28 (about 15%) are in mainland China; the countries named most often are United States (66), Mainland China (28) and United Kingdom (14). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Nanomedicine?
According to LetPub and DOAJ records, International Journal of Nanomedicine is indexed in SCIE, Scopus and DOAJ.
Is International Journal of Nanomedicine open access, and what is the APC?
International Journal of Nanomedicine is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .